UPUMS Nsg officer-2023
Mental Health Nursing
Hard

Dexamethasone suppression test is used to diagnose depression based on the concept that?

Appeared in: UPUMS Nsg officer-2023

Explanation

  • The core concept behind the Dexamethasone Suppression Test (DST) for depression is the well-documented hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in many affected patients.
  • This HPA axis hyperactivity leads to an overproduction and excessive secretion of cortisol, a state known as hypercortisolemia.
  • The DST works by introducing dexamethasone, a synthetic glucocorticoid. In a healthy person, this causes suppression of natural cortisol production via negative feedback.
  • In many depressed patients, this feedback mechanism is faulty. Their cortisol levels are not suppressed by the dexamethasone, which unmasks the underlying hypersecretion.
  • Therefore, the test's utility is directly based on the premise that depressed patients exhibit hypersecretion of cortisol due to a dysregulated HPA axis.

Why Other Options Were Wrong

  • Option B: Dexamethasone is a corticosteroid used for its anti-inflammatory and immunosuppressant effects, and in this context, as a diagnostic agent. It does not have inherent antidepressant properties and is not used as a treatment for depression.
  • Option C: While it is a true statement that dexamethasone is a steroid, this fact alone does not explain the principle of the test. The concept relies on the body's abnormal response to the steroid in the context of depression, not simply the drug's classification.
  • Option D: This is the direct opposite of the neuroendocrine abnormality observed. Major depression is associated with hypersecretion (an excess) of cortisol, not hyposecretion (a deficiency).

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Physiological basis of the Dexamethasone Suppression Test (DST) in diagnosing depression as background academic context rather than a clinical decision trigger.
  • The DST is considered a 'state marker,' meaning an abnormal result reflects the current depressive episode and often normalizes upon recovery. It is not a 'trait marker' for a lifelong vulnerability to depression.
  • The test has low specificity, as abnormal results can also be seen in other psychiatric conditions (like eating disorders, OCD) and medical conditions (like Cushing's syndrome), limiting its routine use for diagnosis.
  • What if the patient's DST result is normal? A normal DST result does not rule out depression. Many patients with depression, particularly those with less severe forms, have a normal HPA axis response.
How to Approach the Question
  • First, identify the key elements of the question: the name of a test (Dexamethasone Suppression Test), the condition it's used for (depression), and the core task (identify the underlying concept).
  • Recall or deduce the function of a 'suppression test'. These tests are designed to see if a biological system can be appropriately turned down or 'suppressed' by a stimulus.
  • Access your knowledge of the pathophysiology of depression. Remember the link between stress, the HPA axis, and cortisol.
  • Connect the test to the pathophysiology. Dexamethasone is a synthetic cortisol. It should suppress the HPA axis. If it fails to do so, it implies the system is overactive and producing too much cortisol on its own.
  • Evaluate the options based on this connection. The option stating hypersecretion of cortisol aligns with the failure of suppression, while hyposecretion is the opposite. The other options are either factually incorrect or irrelevant to the test's mechanism.
Concept Tested & Keywords
  • Concept Tested: Physiological basis of the Dexamethasone Suppression Test (DST) in diagnosing depression.
  • Stem keywords: Dexamethasone suppression test, diagnose depression, concept
  • Lead-in keywords: based on the concept that

Question ID

QYHEQn7I9GsARASgyGHxIp

Reference Book

E6 Medicine Harrison 22e Part 2 p. 954-956

E6 Gynecology Williams p. 357-425

E6 Robert Boland, Marcia L. Verduin - Kaplan and Sadock's Comprehensive Text of Psychiatry-Wolters Kluwer Health (2024) (pp 1-16525 of 16525) p. 514-516

Practise the full UPUMS Nsg officer-2023

Attempt every question from this paper in a timed mock, then review the full solution for each one.